Nota Clínica

Food borne-botulism during SARS-CoV-2 pandemic time. A case and a possible familial outbreak in Barcelona

V. Casado-Ruiz, A. Cano, A. Suárez-López, D. Muriana, N. Guanyabens-Buscà, P. Sanz-Cartagena, M. Álvarez-Larruy, E. Palomeras [REV NEUROL 2022;75:71-74] PMID: 35879883 DOI: https://doi.org/10.33588/rn.7503.2021294 OPEN ACCESS
Volumen 75 | Number 03 | Nº of views of the article 6.533 | Nº of PDF downloads 85 | Article publication date 01/08/2022
Icono-PDF-OFF Download PDF Castellano Icono-PDF-OFF Download PDF English Citation Search in PubMed
Share in: Facebook Twitter
Go to another issue
ABSTRACT Artículo en español English version
INTRODUCTION Botulism is a potentially fatal neuroparalytic syndrome caused by Clostridium botulinum neurotoxin. The 25% are food-borne botulism cases.

CASE REPORT We describe a confirmed case of botulism attended in our hospital in September 2020, together with a second case in a patient’s relative, suspected but not confirmed by laboratory tests. Clinical presentation consisted on general weakness, bilateral cranial palsy, mydriasis, and rapidly progressive tetraparesis in case 1, involving respiratory and swallowing function so she required hospitalization and support treatment. Non specific and transient symptoms occurred in case 2. SARS-CoV-2 infection was initially suspected in both cases due to pandemic situation in our country, ruled out by negative PCR. When B neurotoxin was detected in stool sample of patient 1 we confirmed the diagnosis of food-borne botulism probably linked to home-made conserved beans. CONCLUSION. Early clinical suspicion, together with laboratory and electromyography findings, and support treatment provided at hospital were crucial for favourable outcome. Being aware of this rare syndrom might contribute to its better management.
KeywordsBotulismCase reportFood-borne botulismNeuroparalyticOutbreakSurveillance
FULL TEXT Artículo en español English version

Introduction


Botulism is a potentially fatal neuroparalytic syndrome caused by Clostridium botulinum neurotoxins (BoNTs). They are very potent toxins produced by the Gram-positive bacterium Clostridium botulinum and some other related Clostridium species ubiquitous in the environment. BoNTs inhibit acetylcholine release at neuromuscular junctions and cholinergic synapsis leading to muscle flaccid descending paralysis, transient but fatal if not treated appropriately. Food-borne botulism (25% of cases of botulism) is rare nowadays. In Spain, 9-13 cases/year of botulism have been reported during last decades [1], still a public health threat.

In this paper we describe a confirmed case of food-borne botulism, probably linked to home-made conserved beans, attended in our hospital in September 2020, together with a second case in a patient’s relative, suspected but not confirmed by laboratory tests. Early clinical suspicion, the same as laboratory and electroyography (EMG) findings, were essential to achieve diagnosis and favourable outcome.

Informed consent for the publication of the case was obtained from the patients.
 

Case report


Confirmed case


A 71 years old woman was attended at the Emergency Ward at Hospital de Mataró (Barcelona, Spain) on 9th September 2020 with progressive weakness, and was admitted to Neurology Ward. Affected by high blood pressure, essential tremor, arthrosis, and mild anxiety disorder, with no other relevant medical history; on current treatment with gabapentin, sertraline and tramadol. She had consulted her General Practitioner on 1st September 2020 because of abdominal pain together with mild diarrhea lasting for 24 hours. The day after she started to feel weak and next days, dyspnea and difficulty swallowing appeared, so laryngitis was suspected and prednisone prescribed. On 8th September 2020 she was re-visited by her General Practitioner with worsening global weakness; she also presented dysarthria, dysphagia and bilateral ptosis, so she was referred to Hospital.

At arrival she did not present fever and physical examination was normal except for moderate tachypnea. Neurological examination showed: bilateral eyelids ptosis, facial palsy, ophthalmoparesis and bilateral mydriasis; four limbs weakness (3/5); and severe dysphonia and dysphagia; she was conscious and speech content was normal, the same as jerks, sensation and coordination. Fatigability manoeuvres were unclear, and an ice-pack test resulted positive

Polymerase chain reaction (PCR) SARS-CoV-2 was negative. Arterial blood test showed hypoxemia (75 mmHg) and the rest of tests done urgently were normal –chest Rx, routine blood test, and electrocardiogram (ECG)–.

Support treatment with O2 and serum therapy were started, so she became stable, and she began slow improvement since day 8 from admission. She continued on rehabilitation therapy for the next weeks, and she was fully recovered when visited at neurology clinics six weeks later.

Suspected case


A 78 years old man, the patient’s husband, had been visited at the Emergency Ward during these days. He was affected by hypertension, diabetes mellitus and chronic obstructive lung disease, stable on his medical treatment. He explained nonspecific symptoms such as asthenia and dizziness during previous days. Physical exam was normal and supplementary exams resulted normal too (chest Rx, ECG, blood and urine test, PCR SARS-CoV-2). He recovered spontaneously, so no more tests were performed since awareness of diagnosis of botulism of his wife. He was then investigated for neurotoxin, and he was negative.

Laboratory investigation


PCR for neurotoxin B resulted positive in patient’s stool, the day 18 from symptoms onset in case 1, when she was severely ill; but negative in patient 2, one week after complete symptoms recovery.

EMG showed pre-synaptic dysfunction at neuromuscular junction, after facilitation manoeuvres, in case 1 (no EMG was performed in case 2). Exams performed, in case 1, in order to exclude entities such as stroke, myasthenia gravis, etc. resulted negative: cranial magnetic resonance imaging, blood test including antibodies acetylcholine receptor and thoracic computerized tomography scan (Figure).

 

Figure. EMG showing an incremental motor response after repeated high-frequency nerve stimulation, suggesting a presynaptic transmission defect, as described for botulism.






 

Discussion


We describe a case of confirmed food-borne botulism probably linked to home-made conserved beans, together with another suspected but non-confirmed case, meaning a domestic outbreak.

Botulism is nowadays a very rare disease, even though, to bear in mind because of its potential fatal prognosis. Subjected to mandatory declaration in Spain, in order to investigate for possible outbreaks, clinical suspicion is essential to treat early and to avoid morbi-mortality.

BoNTs are classified into seven serotypes, from A to G. The confirmatory microbiological diagnosis of botulism is based on the detection of botulinum toxin in serum, stool –as in our case-, gastric aspirate and/or food. The presence of C. botulinum in food may be useful but not confirmatory for the diagnosis, since the botulinum spores are very widely distributed. In Spain, these tests are performed in a reference laboratory at the National Center of Microbiology.

In recent decades, few cases and outbreaks have been reported in the literature, e.g. in Finland [2] caused by spoiled tinned olives. In Spain, we also found reports of cases in Guadalajara [3], in the Community of Madrid [1] and in Barcelona, the latter involving two simultaneous outbreaks in 2012 [4]. A recent article reviewed the disease in France from 1875 to 2016 [5]. Type B toxin is the most prevalent, and food tinned at home is the main cause of food-borne botulism, although in half of the incidents exactly which contaminated food was the cause remains unknown, as is the case here.

It is also interesting to mention the cases of botulism related to inhaled cocaine, both in our country [6] and in France [7], in the early years of the 21st century,

Dysautonomic involvement has been described in botulism, and as a consequence of other pathogens [8]. In the cases described here, this consisted of arterial hypotension, which improved in case 1 during the first week of hospitalisation and in case 2 over another 15 days, during which the patient repeatedly visited the emergency department. In case 1, mydriasis, ophthalmoparesis, dysphagia and finally tetraparesis were subsequently improved.

With regard to specific treatment with antitoxin serum, it was not indicated in our case, given the delay between the onset of symptoms and hospital admission. The clinical course was favourable with supportive medical treatment and the condition resolved completely within six weeks. This recovery occurred, as classically described, gradually and in the reverse order in which the different symptoms had appeared.

Another point of interest in our case was the positivity we found of ice pack test, as usually described in myasthenia gravis, but also in botulism [9]. This easy and available test might be useful for diagnosis, together with clinical and electromyography findings as in our case [10].

Except for the notification to every possible patient’s relative/meal sharing, no public Health measures were needed. The suspicious food sample was already lacking at hospital admission, so the food-borne botulism linkage could not be established. Only the patient 1 and 2 we described here -with no other people living at their home- ate the suspicious sample referred. 
 

Conclusion


Albeit rare, C. botulinum is still present in our society. We consider awareness and clinical suspicion of botulism essentials to achieve a favourable outcome.

 

References
 


 1. Gaida D, Junco A, Álvarez-Moreno M, Rodero I, Carneado-Ruiz J. Familial microepidemic of food borne botulism in the Region of Madrid. Rev Neurol 2016; 63: 28-32.

 2. Jalava K, Selby K, Pihlajasaari A, Kolho E, Dahlsten E, Forss N, et al. Two cases of food-borne botulism in Finland caused by conserved olives, October 2011. Euro Surveill 2011; 16: 20034.

 3. García-Gálvez P, Hernández-Cristóbal J, Sebastián-Cambón R, Fernández-Carril JM, Marian-Crespo C, Gimeno-Fernández C. Dos casos de botulismo alimentario en pacientes mayores de 75 años [Two cases of food-borne botulism in patients over 75 years of age]. Rev Neurol 2014; 59: 286-8.

 4. Lafuente S, Nolla J, Valdezate S, Tortajada C, Vargas-Leguas H, Parron I, et al. Two simultaneous botulism outbreaks in Barcelona: C. baratii and C. botulinum. Epidemiol Infect 2013; 141: 1993-5.

 5. Rassetti-Escargueil C, Lemichez E, Popoff MR. Human botulism in France, 1875-2016. Toxins 2020; 12: 338.

 6. Aguirre-Balsalobre F, González-Herrera M, Mengual-Verdú E, García-Conca V, Hueso-Abancens JR. Simultaneous botulism in two brothers addicted to cocaine. Arch Soc Esp Oftalmol 2007; 82: 583-6.

 7. Roblot F, Popoff M, Carlier JP, Godet C, Abbadie P, Matthis S, et al. Botulism in patients who inhale cocaine: the first cases in France 2006; 43: e51-2.

 8. Carod-Artal FJ. Infectious diseases causing autonomic dysfunction. Clin Auton Res 2018; 28: 67-81.

 9. Cosentino G, Alfonsi E, Lonati D, Locatelli CA, Valentino F, Brighina F. Positive ice pack test in a case of food-borne botulism. J Neurol 2012; 259: 2486-7.

 10. Forss N, Ramstad R, Backlund T, Lindstrom M, Kolho E. Difficulties in diagnosing food-borne botulism. Case Rep Neurol 2012; 4: 113-5.

 

Botulismo alimentario durante la pandemia por el SARS-CoV-2. Descripción de un caso y de un posible brote familiar en Barcelona

Introduction. El botulismo es un síndrome neuroparalítico hoy en día infrecuente, potencialmente fatal, causado por neurotoxinas de Clostridium botulinum. El origen es alimentario en el 25% de los casos.

Caso clínico. Describimos el caso confirmado de botulismo alimentario en una paciente atendida en nuestro hospital en septiembre de 2020 y la sospecha de un segundo caso en un familiar de la paciente, no confirmado éste por las pruebas de laboratorio. La instauración en pocos días de una afectación bilateral de pares craneales, incluyendo disfagia, disnea y disartria, junto con midriasis y tetraparesia graves, precedida de diarrea, constituyó la presentación clínica en el primer caso; mientras que en su familiar cursó con síntomas inespecíficos y transitorios. Constatamos disautonomía consistente en hipotensión arterial en ambos casos. Teniendo en cuenta la situación pandémica en aquel momento, se descartó repetidamente la infección por SARS-CoV-2 antes de plantear alternativas diagnósticas. La neurotoxina B de C. botulinum fue detectada en las heces de la paciente, confirmando el diagnóstico de botulismo, que relacionamos con la ingesta de una conserva casera de alubias. Se completó el diagnóstico diferencial del cuadro descartando otras posibles etiologías.

Conclusión. La sospecha clínica temprana, confirmada con los hallazgos de laboratorio y neurofisiológicos y que llevaron al manejo específico de la paciente, fueron cruciales para la evolución favorable. No fue necesario aplicar medidas de salud pública, a excepción de la notificación a sus allegados de la contaminación detectada. Conocer la existencia de esta patología puede contribuir a su pronóstico.

Palabras clave. Botulismo alimentario. Caso clínico. C. botulinum. Midriasis. Neuroparalítico. Tetraparesia.
 

 

© 2022 Revista de Neurología

Si ya es un usuario registrado en Neurologia, introduzca sus datos de inicio de sesión.


Rellene los campos para registrarse en Neurologia.com y acceder a todos nuestros artículos de forma gratuita
Datos básicos
He leído y acepto la política de privacidad y el aviso legal
Seleccione la casilla si desea recibir el número quincenal de Revista de Neurología por correo electrónico. De forma quincenal se le mandará un correo con los títulos de los artículos publicados en Revista de Neurología.
Seleccione la casilla si desea recibir el boletín semanal de Revista de Neurología por correo electrónico. El boletín semanal es una selección de las noticias publicadas diariamente en Revista de Neurología.
Seleccione la casilla si desea recibir información general de neurologia.com (Entrevistas, nuevos cursos de formación, eventos, etc.)
Datos complementarios

Se os solicita los datos de redes para dar repercusión por estos medios a las publicaciones en las que usted participe.



Estimado usuario de Revista de Neurología,

Debido a la reciente fusión por absorción de VIGUERA EDITORES, S.L.U., la entidad gestora de las publicaciones de Viguera Editores, entre ellas, Revista de Neurología, por EVIDENZE HEALTH ESPAÑA, S.L.U., una de las sociedades también pertenecientes al Grupo Evidenze, y con la finalidad de que Usted pueda seguir disfrutando de los contenidos y distintos boletines a los que está suscrito en la página web de neurologia.com, es imprescindible que revise la nueva política de privacidad y nos confirme la autorización de la cesión de sus datos.

Lamentamos informarle que en caso de no disponer de su consentimiento, a partir del día 28 de octubre no podrá acceder a la web de neurologia.com

Para dar su consentimiento a seguir recibiendo la revista y los boletines de neurologia.com vía correo electrónico y confirmar la aceptación de la nueva política de privacidad, así como la cesión de sus datos a Evidenze Health España S.L.U., el resto de las entidades del Grupo Evidenze y sus partners y colaboradores comerciales, incluyendo la posibilidad de llevar a cabo transferencias internacionales a colaboradores extranjeros, pulse en el siguiente enlace:

ACEPTAR

Cancelar

Atentamente

El equipo de Revista de Neurología